|
Re: Sorry fuzz, believe I copied one of yours
|
8
|
Resverlogix Corp.
|
Oct 24, 2016 11:18PM
|
|
Debenture
|
8
|
Resverlogix Corp.
|
Sep 27, 2019 10:45AM
|
|
Re: Resverlogix In Active Discussions With The Kingdom of Morocco’s Ministry of Health For The Launch Of COVID-19 Clinical Studies With First-In-Class Dru
|
8
|
Resverlogix Corp.
|
Nov 01, 2021 10:38AM
|
|
Re: Updated Van Leeuwenhoeck Institute Analyst Report and August Fact Sheet
|
8
|
Resverlogix Corp.
|
Aug 02, 2018 06:51PM
|
|
Re: German drug maker Morphosys to buy Constellation Pharma in $1.7 billion deal
|
8
|
Zenith Epigenetics
|
Jun 05, 2021 07:23PM
|
|
Re: Differences of Opinion
|
8
|
Zenith Epigenetics
|
May 24, 2016 04:25PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
8
|
Resverlogix Corp.
|
Apr 29, 2022 12:29PM
|
|
Re: Article
|
8
|
Resverlogix Corp.
|
May 30, 2022 11:40AM
|
|
Re: Surf's up
|
8
|
Resverlogix Corp.
|
Feb 06, 2020 12:43PM
|
|
Re: Merck and Pfizer competition for a COVID 19 pill (Stat News)
|
8
|
Resverlogix Corp.
|
Apr 09, 2021 02:07PM
|
|
Re: Resverlogix In Active Discussions With The Kingdom of Morocco’s Ministry of Health For The Launch Of COVID-19 Clinical Studies With First-In-Class Dru
|
8
|
Resverlogix Corp.
|
Nov 01, 2021 12:07PM
|
|
Re: Zenith and Newsoara Biopharma Announce Expanded Licensing and Investment.
|
9
|
Zenith Epigenetics
|
Nov 17, 2021 10:12AM
|
|
Re: Market Cap Context
|
9
|
Resverlogix Corp.
|
Jul 05, 2019 10:34AM
|
|
Re: Hong Kong stock exchange IPO
|
9
|
Resverlogix Corp.
|
Apr 25, 2018 10:11AM
|
|
Re: Share price, why we stay
|
9
|
Resverlogix Corp.
|
Nov 19, 2020 05:44PM
|
|
Maybe timing is everything…
|
9
|
Resverlogix Corp.
|
Jun 02, 2023 02:44PM
|
|
Re: Stability
|
9
|
Resverlogix Corp.
|
Nov 23, 2015 02:21PM
|
|
Re: More options exercised, this time by Ewelina Kulikowski
|
9
|
Resverlogix Corp.
|
Jul 13, 2018 05:02PM
|
|
Re: Pointing in the right direction & bogus Lilly
|
9
|
Resverlogix Corp.
|
Jun 21, 2018 09:20AM
|
|
Scaffolds
|
9
|
Resverlogix Corp.
|
Sep 22, 2016 01:32PM
|
